Side-by-side financials for BTMD and RGC. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BTMD | RGC |
|---|---|---|
| Market cap | - | $9.74 B |
| US-listed rank | - | #969 |
| Revenue (latest FY) | $192.22M | - |
| Net income (latest FY) | $27.05M | -$3.58M |
| Net margin | 14.1% | - |
| SEC filings | 398 | 82 |
Full pages: biote Corp. and Regencell Bioscience Holdings Ltd, or browse the full rankings.